Cargando…

Alternative splicing, FOXP3 and cardiovascular disease

Detalles Bibliográficos
Autores principales:	Joly, Anne-Laure, Andersson, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503886/ https://www.ncbi.nlm.nih.gov/pubmed/30981208 http://dx.doi.org/10.18632/aging.101897

Ejemplares similares

IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
por: Mailer, Reiner K. W., et al.
Publicado: (2015)

Alternative Splicing of FOXP3—Virtue and Vice
por: Mailer, Reiner K. W.
Publicado: (2018)

IPEX as a Consequence of Alternatively Spliced FOXP3
por: Mailer, Reiner K.
Publicado: (2020)

Alternative Splicing in Human Physiology and Disease
por: Artemaki, Pinelopi I., et al.
Publicado: (2022)

Alternative Splicing and Gene Duplication in the Evolution of the FoxP Gene Subfamily
por: Santos, M. Emília, et al.
Publicado: (2011)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases
por: Dlamini, Zodwa, et al.
Publicado: (2015)

Alternative Splicing: Role in Cancer Development and Progression
por: Sette, Claudio, et al.
Publicado: (2013)

Alternative Splicing: Recent Insights into Mechanisms and Functional Roles
por: Ghigna, Claudia, et al.
Publicado: (2020)

Alternative Splicing in Cardiovascular Disease—A Survey of Recent Findings
por: Hasimbegovic, Ena, et al.
Publicado: (2021)

Role of Complementary and Alternative Medicine in Cardiovascular Diseases
por: Qidwai, Waris, et al.
Publicado: (2013)

Complementary/Alternative Medicine in Cardiovascular Diseases 2013
por: Chen, Ke-ji, et al.
Publicado: (2013)

Complementary/Alternative Medicine in Cardiovascular Diseases 2014
por: Chen, Ke-Ji, et al.
Publicado: (2015)

Survival-associated alternative splicing signatures in soft tissue sarcomas
por: Ren, Xianghai, et al.
Publicado: (2020)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Alternative Splicing: From Abiotic Stress Tolerance to Evolutionary Genomics
por: Gao, Bei, et al.
Publicado: (2023)

The Potential Benefit of Complementary/Alternative Medicine in Cardiovascular Diseases
por: Chen, Ke-ji, et al.
Publicado: (2012)

FOXP3-microRNA-146-NF-κB as oncotarget
por: Etikala, Deepa M., et al.
Publicado: (2015)

Alternative splicing regulation at tandem 3′ splice sites
por: Akerman, Martin, et al.
Publicado: (2006)

Identity of mysterious CD4(+)CD25(-)Foxp3(+ )cells in SLE
por: Horwitz, David A
Publicado: (2010)

Alternative Splice in Alternative Lice
por: Tovar-Corona, Jaime M., et al.
Publicado: (2015)

Alternative Splicing in Alzheimer’s Disease
por: Love, Julia E., et al.
Publicado: (2015)

Post-Exercise Hypotension: An Alternative Management Strategy for Hypertension and Cardiovascular Disease?
por: Aly, Khaled, et al.
Publicado: (2023)

Post-Transcriptional Modification by Alternative Splicing and Pathogenic Splicing Variants in Cardiovascular Development and Congenital Heart Defects
por: Mehta, Zubin, et al.
Publicado: (2023)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Splicing: is there an alternative contribution to Parkinson’s disease?
por: La Cognata, Valentina, et al.
Publicado: (2015)

Editorial: Alternative Splicing in Health and Disease
por: Kahraman, Abdullah, et al.
Publicado: (2022)

Alternative splicing of acrosin binding protein RNA transcript and its potential contributions to innovative cancer therapy
Publicado: (2020)

Alternative splicing of HER2: a novel mediator of EGFR TKI resistance
por: Yochum, Zachary A., et al.
Publicado: (2020)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

A novel DNA damage-induced alternative splicing pathway that regulates p53 and cellular senescence markers
por: Chen, Jing, et al.
Publicado: (2017)

Promiscuous Foxp3-cre activity reveals a differential requirement for CD28 in Foxp3(+) and Foxp3(−) T cells
por: Franckaert, Dean, et al.
Publicado: (2015)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Alternative splicing in cardiomyopathy
por: Beqqali, A.
Publicado: (2018)

The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate
por: Hirano, Minato, et al.
Publicado: (2023)

Alternative splicing in osteoclasts and Paget’s disease of bone
por: Klinck, Roscoe, et al.
Publicado: (2014)

Alternative Splicing for Diseases, Cancers, Drugs, and Databases
por: Tang, Jen-Yang, et al.
Publicado: (2013)

Alternative RNA Splicing in the Pathogenesis of Liver Disease
por: Webster, Nicholas J. G.
Publicado: (2017)

Alternative RNA Splicing in Fatty Liver Disease
por: Wu, Panyisha, et al.
Publicado: (2021)

An alternative splicing signature in human Crohn’s disease
por: Li, Daowei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_11j3daue4dfcc391160hogq7s5